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Background. Endothelial dysfunction occurs in obese children and adolescent and is regarded as a key step in the development of
atherosclerosis. Important components for the development of endothelial dysfunction are reduced activity of endothelial nitric
oxide synthase (eNOS) and an increase in cholesterol deposition in the vessel wall, due to reduced reverse cholesterol transport
(RCT) activity. High density lipoprotein (HDL) exhibits antiatherosclerotic properties including modulation of eNOS activity
and cholesterol efflux capacity. Lifestyle intervention programs can modify endothelial dysfunction in obese adolescents, but
their impact on HDL-mediated eNOS activation and RCT is unknown so far. Methods. Obese adolescents (15 ± 1 years, BMI >
35 kg/m2) where randomized either to an intervention group (IG, 𝑛 = 8; restricted diet and exercise) or to a usual care group (UC,
𝑛 = 8). At the beginning and after 10 months of treatment HDL-mediated eNOS phosphorylation and cholesterol efflux capacity
were evaluated. Results. Ten months of treatment resulted in a substantial weight loss (−31%), an improvement of endothelial
function, and an increase inHDL-mediated eNOS-Ser1177 phosphorylation andRCT.A correlation between change in eNOS-Ser1177
phosphorylation or RCT and change in endothelial function was noted. Conclusion. A structured lifestyle intervention program
improves antiatherosclerotic HDL functions, thereby positively influencing endothelial function.
1. Introduction
Adolescent obesity is rising at an alarming rate. The world-
wide prevalence of childhood overweight/obesity increased
from 4.2% in 1990 to 6.7% in 2010, and it is predicted to reach
9.1% in 2020 [1]. Obesity is closely related tomultiple diseases
such as type two diabetes mellitus, coronary artery disease,
hypertension, dyslipidemia, and fatty liver disease [2] and is a
predictor of an increased risk for cardiovascular disease and
its related mortality [3, 4]. Endothelial function is impaired
in up to 50% of prepubertal and pubertal obese children
[5, 6].Themost important factor for regulating endothelium-
dependent vasodilation is the bioavailability of nitric oxide
(NO), which depends on its synthesis by endothelial nitric
oxide synthase (eNOS) and degradation by reactive oxygen
species (ROS).The activity of eNOS can be regulated bymod-
ulating its RNA/protein expression or by phosphorylation of
the enzyme at specific sites, like serin-1177 and threonine-495
[7].
High density lipoprotein (HDL) is a complex organized
particle which inversely relates to the risk of myocardial
infarction and even death [8]. Unfortunately, all efforts to
increaseHDL concentration by pharmaceutical interventions
in adults failed to result in changes in cardiovascular risk or
recurrent cardiovascular events [9].Therefore, in recent years
the functional aspect ofHDL, and not only the concentration,
has become more and more important [10]. Besides promot-
ing reverse cholesterol transport and its anti-inflammatory
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action [11], recent studies documented that HDL also reg-
ulates NO bioavailability by modulating eNOS enzymatic
activity [12–14]. This ability to activate eNOS via phospho-
rylation is impaired in diabetes [15], heart failure [12], and
obesity [16].
Since pharmaceutical and surgical treatment option are
very limited to fight childhood and adolescent obesity,
lifestyle interventions involving nutrition and physical activ-
ity are crucial. In a recent clinical study we could show that an
intervention combining supervised diet and exercise training
decreased BMI and body fat significantly and resulted in an
improved endothelial function when compared to a usual
care group [17]. Whether this improvement in endothelial
function is accompanied by an improvement in HDL func-
tion (eNOS phosphorylation and cholesterol efflux) remains
unclear. In a small cohort of obese children a defined 6-month
lifestyle intervention resulted in no change in HDL-mediated
phosphorylation of eNOS [16]. It is important to note that the
lifestyle intervention in that specific study was not sufficiently
effective in reducing the body weight so that the children
were still classified as obese at the end of the program. A
study in obese women showed a strong correlation between
the change in body weight and the change in cholesterol
efflux capacity but also noted that a substantial weight loss
is necessary to improve reverse cholesterol transport [18].
To critically assess if lifestyle intervention can modify
HDL function in obese adolescents, we assessed HDL-
mediated eNOS phosphorylation and RCT in obese adoles-
cents participating in a 10-month lifestyle intervention pro-
gram which empowered the participants to lose a substantial
amount of weight.
2. Methods
2.1. Patient Population, Blood Sampling, and Endothelial
Function. The patients analyzed in the present study are a
subgroup of the patients recently engaged in a trial investi-
gating the impact of diet and exercise on endothelial function
in obese adolescents [17]. Eight adolescents from the inter-
vention group and 8 individuals from the usual care group
were selected. Groups were matched for age, sex, pubertal
development, BMI, and physical activity. Blood was taken
before randomization (lifestyle intervention or usual care) at
study begin and after 10 months. Serum was isolated by cen-
trifugation and stored at −80∘C until analyzed. Endothelial
function was measured with pulse amplitude tonometry [17].
2.2. Lifestyle Intervention Program. A detailed description of
the intervention program is described in our recent publi-
cation [17]. In general the intervention program (10-month
duration) included dietary restriction (1500–1800 kcal/day),
supervised physical activity, and psychological support.
Adolescents in the usual care group were treated by
their general pediatrician, focusing on caloric restriction and
encouragement to participate in sports activities.
2.3. HDL Isolation. HDLwas isolated by sequential ultracen-
trifugation according to the method originally described by
Havel et al. using solid potassium bromide for density adjust-
ment [19]. In brief, the density of serum was raised to 1.006
by the addition of potassium bromide (KBr) and subjected
to ultracentrifugation (24 h, 4∘C, and 50,000 rpm, TV-865
rotor). After centrifugation, the lower half was transferred to
a new tube and the density was adjusted to 1.036 with KBr.
After centrifugation (same conditions as above) the lower half
of this second stepwas transferred again to a new tube and the
density was adjusted to 1.21 with KBr.The tube was subjected
again to centrifugation (same conditions as above). After this
last centrifugation the HDL (yellow band) in the upper half
of the tube was collected. The quality of isolated HDL was
evaluated by polyacrylamide gel electrophoresis followed by
Coomassie Brilliant Blue staining.
2.4. Cell Culture Experiments and Western Blot Analysis.
Human aortic ECs (HAEC; Cell Systems Biotechnology,
Troisdorf, Germany) were cultured in EGM-2 cell culture
medium (Lonza,Walkersville,MD) and incubated for 0, 5, 10,
15, 30, or 60minutes with 50 𝜇g/mL isolatedHDL.Thereafter,
cells were harvested with ice-cold lysis buffer (50mmol/L
Tris-HCl; pH 7.4; 1% NP-40; 0.25% Na-deoxycholate;
150mmol/L NaCl; 1mmol/L EDTA; 0.1% Triton X-100; 0.2%
SDS) containing protease inhibitormixM(Serva,Heidelberg,
Germany) as well as phosphatase inhibitor mix II (Serva).
Protein concentrationwas determined using BSA as standard
(BCA method; Pierce, Rockford, IL).
Tenmicrograms of total protein was separated on a dena-
turing polyacrylamide gel and transferred to a PVDF mem-
brane. To detect specific proteins, the following antibodies
were applied: anti-eNOS (Santa Cruz), antiphospho-eNOS-
Ser1177, antiphospho-eNOS-Thr495 (both BD Biosciences,
Heidelberg, Germany). For the evaluation of HDL-induced
phosphorylation of eNOS, the maximal stimulation was used
as recently described [12, 16]. All samples were analyzed in
triplicate.
2.5. Cholesterol Efflux Assay. Cholesterol efflux, mediated
by the ATP-binding cassette transporter A1 (ABCA1), was
measured in duplicate using 3[H]-cholesterol (Perkin Elmer,
Boston, MA, USA) labelled J744 macrophages and apolipo-
protein B- (ApoB-) depleted serum as recently described
[20]. In brief, ApoB depleted serum was generated by mixing
100 𝜇L patient serumwith 40 𝜇L of polyethylene glycol (PEG,
40% in glycine buffer pH 7.4). After incubating the mixture
for 20 minutes at room temperature and centrifugation
(30min, 10,000×g, 4∘C) the supernatant (ApoB depleted
serum) was collected and frozen at −80∘C until used in
the cholesterol efflux assay. J774 macrophages were grown
overnight at a density of 300,000/cm2 in DMEM (Gibco)
supplemented with 10% FCS and Penicillin/Streptomycin
(Pen/Strep, Sigma). The following day medium was
replaced by DMEM supplemented with 10% FCS, Pen/Strep,
2 𝜇g/mL Sandoz 58-035 (Sigma), 0.3mM 8-(4-chlorophenyl-
thio)cyclic-AMP (Sigma), and 1 𝜇Ci/mL 3[H]-cholesterol.
The next morning the medium was removed and the cells
were incubated for 2 h with DMEM (serum free), Pen/Strep
and 0.2% BSA fat free to remove cholesterol not incorporated
into the cell membrane. Subsequently, efflux medium































































































































Figure 1: Impact of lifestyle intervention program on HDL-mediated eNOS phosphorylation. Ten months of intervention increases HDL-
mediated eNOS-Ser1177 phosphorylation in the intervention group when analyzed over time (a) or compared to usual care group (UC) (b).
No change in HDL-mediated eNOS-Ser1177 phosphorylation occurs in UC (c). Phosphorylation of the eNOS-Thr495 residue was not affected
by the intervention program when compared to UC (d).
(DMEM serum free) containing 2.8% apolipoprotein B-
depleted serum was added to the cells and incubated for 3 h.
Liquid scintillation counting of the cell supernatant and the
lysed cells was used to calculate the % efflux capacity.
2.6. Statistical Analyses. Data are presented as mean ± SD.
Normal distribution of the data was tested (Kolmogorov and
Smirnov test), and between-group differences were assessed
by paired or unpaired 𝑡-test. Significance was accepted as
𝑝 < 0.05. Analyses were performed by SPSS version 22 (SPSS
Inc., Chicago, USA).
3. Results
3.1. Patient Characteristics. At study beginning there was
no significant difference in baseline characteristics of the
individuals randomized either to the control or to interven-
tion group (Table 1). All study participants were severely
overweight with a BMI above 35. In the intervention group,
10months of lifestyle intervention resulted in a 32% reduction
in BMI (𝑝 < 0.001), a 41% reduction in body fat (𝑝 < 0.001),
and a 10% increase in maximal oxygen uptake (𝑝 = 0.002).
Endothelial function showed a trend towards improvement
but did not reach statistical significance (max. dilation 𝑝 =
0.072), whereas the pulse wave velocity, a marker for the ves-
sel stiffness, decreased significantly in the intervention group.
In the usual care group no changes in the aforementioned
parameters were detected after 10 months.
3.2. HDL-Mediated eNOS Phosphorylation. The HDL-medi-
ated phosphorylation at position Ser1177 of eNOS signif-
icantly improved in the intervention group (Figure 1(a)).
Calculating the % change over the intervention period of
10 months, a significant difference between the intervention
group and the usual care was detected (Figure 1(b)). In the
intervention group a 73% increase in Ser1177 phosphorylation
was evident. In the usual care group no difference in eNOS-
Ser1177 phosphorylation was found at start versus study
end (Figure 1(c)). There was no significant difference in %
change of HDL-mediated eNOS phosphorylation at Thr495
(Figure 1(d)). A correlation (𝑟 = 0.54, 𝑝 = 0.046) was evident
between changes in eNOS-Ser1177 phosphorylation and the
change in endothelial function, measured as max. dilation.



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2: Impact of lifestyle intervention program on cholesterol efflux capacity. Individual changes were observed in the intervention group
(IG) (a) and the usual care group (UC) (b). Comparing the change in cholesterol efflux capacity between IG and UC group (c) a significant
difference was obvious.
3.3. Reverse Cholesterol Efflux. When analyzing the efflux
capacity of HDL from adolescents in the usual care and inter-
vention group, at 10months a decline (𝑝 = 0.05)was observed
in the usual care group (Figure 2(a)), whereas an increase
(𝑝 = 0.08) was noted in the intervention group (Figure 2(b)).
Accordingly, the change in HDL efflux capacity from study
beginning to end was significantly higher in the adolescents
from the intervention group than those who received usual
care (Figure 2(c)).Therewas amoderate correlation (𝑟 = 0.56,
𝑝 = 0.035) between the changes in efflux capacity and the
change in endothelial function, measured as max. dilation.
4. Discussion
Obesity and low physical activity have negative effects on
endothelial function, whereas lifestyle interventions can
attenuate or even reverse this process. One factor able to
influence endothelial function is HDL via its modulation of
reverse cholesterol transport and activation of eNOS. Several
findings emerge from the present study.
First, the phosphorylation of eNOS at the activating site
Ser1177 was improved by a 10-month intervention program
which combined dietary restriction, physical activity, and
psychological support. No change in HDL-mediated phos-
phorylation at the Thr495 residue was shown. Second, the
decline in HDL-mediated cholesterol efflux was increased by
the intervention program.
Third, correlations between the change in eNOS phos-
phorylation at Ser1177 or the efflux capacity and the change
in endothelial function were observed. These correlations
support the importance of the changes in HDL function for
influencing endothelial function.
Taken together, the results of the present study doc-
umented that an intervention program, able to achieve
significant weight loss, has beneficial effects onHDL function
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(eNOS activation and cholesterol efflux). This effect on HDL
function may be one way how lifestyle intervention is able
to improve endothelial function and reduces the risk of
developing atherosclerosis.
4.1. Lifestyle Intervention Program and Impact on HDL-
Mediated eNOS Activation. Studies have shown that HDL,
acting via the SR-B1 receptor, can activate eNOS to generate
NO [21, 22] and induce vasodilation [14]. In particular, HDL
targets the activation of eNOS via the phosphorylation at
specific sites – Ser1177 (activation of the enzyme) and Thr495
(inhibition of the enzyme). In the present study a significant
increase in HDL-mediated eNOS-Ser1177 phosphorylation
was detected in the group assigned to the 10 months’ lifestyle
intervention program when compared to the usual care
group. No change was documented at the eNOS-Thr495
residue. This result differs in some aspects to a recently
published study by our group, documenting that lifestyle
intervention as well as bariatric surgery did not affect HDL-
mediated eNOS phosphorylation [16]. A possible explanation
for this difference is that in the earlier study the patients
remained obese (BMI-SDS above 2 and BMI percentile above
97%) even after 6 or 12 months of intervention, whereas the
adolescents in the present study lost significant weight and
can be classified as normal (BMI around 25 kg/m2; BMI-SDS
around 1.1). This observation supports the hypothesis formu-
lated in the previous study [16] that a certain threshold in
bodyweight has to be reached by the intervention program in
obese adolescents, before a significant effect onHDL function
can be achieved.This is further supported by a study in over-
weight/obese women, where a diet intervention (6-month
duration) did not alter eNOS activity [23]. In that study
the intervention elicited only minor changes in body weight
(minus 2.3%) and fat mass (minus 3%) when compared to
the present one (body weight minus 31% and fat mass minus
41%).
One could wonder whether this HDL-induced change in
eNOS phosphorylation is physiologically relevant. In an ele-
gant study Teupe and colleagues documented that gene trans-
fer of an eNOS construct, mimicking the phosphorylation of
eNOS at Ser1177, resulted in an enhancedNO-mediated relax-
ation of bradykinin-stimulated porcine coronary arteries
[24]. In the present study the change inHDL-mediated eNOS
phosphorylation at Ser1177 and the change in endothelial
function showed a positive correlation. Therefore, the HDL-
mediated increase in eNOS-Ser1177 phosphorylation elicited
by the intervention programmay contribute to improvement
of endothelial function in obese adolescents.
4.2. Lifestyle Intervention Program and Impact on HDL-
Mediated Cholesterol Efflux. A key function of HDL is to
promote reverse cholesterol transport from the periphery
back to the liver.The critical step in this process is the choles-
terol efflux from macrophages to HDL. This macrophage-
specific cholesterol efflux capacity has been causally linked
to atherosclerosis [25] and therefore an elevated cholesterol
efflux capacity is inversely associated with the incidence of
cardiovascular events [26]. Is a lifestyle intervention program
capable of improvingHDL-mediated cholesterol efflux capac-
ity in obese individuals? In the present study the combination
of restrictive diet and an exercise program over 10 months
improved HDL-mediated efflux capacity significantly when
compared to the usual care group (Figure 2). This finding
is supported by 2 other studies [18, 23] where lifestyle
intervention programs had a positive impact on cholesterol
efflux capacity. It is worthwhile to note that in the study by
Lesná et al. [18] a negative correlation was noted between the
change in weight loss and the improvement in efflux capacity.
The authors further concluded that it is necessary to decrease
body weight for more than 4-5% to reach a biological signifi-
cant increase in reverse cholesterol transport.The physiologi-
cal relevance of the change in cholesterol efflux capacity is
further supported by its positive correlation with the change
in endothelial function.
4.3. Study Limitations. The results of the present study sug-
gest that restoring HDL function, measured as HDL-induced
eNOS phosphorylation and cholesterol efflux capacity, by
lifestyle interventions improves endothelial function. This
assumption is only based on correlation analysis but direct
experimental evidence like HDL-induced vasodilation of
aortic rings in an organ bath setting is missing. Therefore,
modulation of other parameters like LDL, C reactive protein
(CRP), or vessel stiffness by lifestyle intervention could also
play an important role for improving vasomotor function.
Improvement of inflammation by lifestyle intervention can be
ruled out, since CRP does not change significantly, whereas
LDL and vessel stiffness change significantly. Therefore,
restoration of HDL function by lifestyle intervention may be
only one out of several parameters potentially modulating
endothelial function.
To gain molecular insights into lifestyle induced modula-
tion of HDL function, a shotgun proteome approach would
be helpful. In a recent study [16], analyzing the impact of a
lifestyle intervention or Roux-en-Y gastric bypass on HDL
function, no change in the overall signature was evident.
4.4. Future Perspectives. It would be interesting to determine
if an improvement in exercise capacity or the significant
weight loss is the driving force to improve HDL function.
Since the present study only analyzed a small group of
adolescents a study with a larger patient cohort is warranted.
In addition the molecular mechanism(s) leading to func-
tional impairment of HDL in obesity still remains unclear.
Future studies have to clarify if differences in protein or lipid
composition of HDL are a reason for impaired function or
whether secondary protein modification, like carbonylation
and methylation, is the key player.
5. Conclusion
In obese adolescents a stringent lifestyle intervention pro-
gram results in enhanced reverse cholesterol transport and
anHDL-mediated activation of eNOS.These effectsmay con-
tribute to improvement of endothelial function.Nevertheless,
to achieve these beneficial effects the lifestyle intervention
Cardiology Research and Practice 7
program should be stringent enough to induce substantial
weight loss.
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change and reverse cholesterol transport in obese women,”
Physiological Research, vol. 58, no. 1, pp. S33–S38, 2009.
[19] R. J. Havel, H. A. Eder, and J. H. Bragdon, “The distribution and
chemical composition of ultracentrifugally separated lipopro-
teins in human serum,”The Journal of Clinical Investigation, vol.
34, no. 9, pp. 1345–1353, 1955.
[20] A. V. Khera, M. Cuchel, M. de la Llera-Moya et al., “Choles-
terol efflux capacity, high-density lipoprotein function, and
atherosclerosis,”TheNew England Journal of Medicine, vol. 364,
no. 2, pp. 127–135, 2011.
[21] I. S. Yuhanna, Y. Zhu, B. E. Cox et al., “High-density lipoprotein
binding to scavenger receptor-BI activates endothelial nitric
oxide synthase,”NatureMedicine, vol. 7, no. 7, pp. 853–857, 2001.
[22] X.-A. Li,W. B. Titlow, B. A. Jackson et al., “High density lipopro-
tein binding to scavenger receptor, class B, type I activates
endothelial nitric-oxide synthase in a ceramide-dependent
manner,” Journal of Biological Chemistry, vol. 277, no. 13, pp.
11058–11063, 2002.
[23] B. O. Aicher, E. K. Haser, L. A. Freeman et al., “Diet-induced
weight loss in overweight or obese women and changes in high-
density lipoprotein levels and function,” Obesity, vol. 20, no. 10,
pp. 2057–2062, 2012.
[24] C. Teupe, S. Richter, B. Fisslthaler et al., “Vascular gene
transfer of phosphomimetic endothelial nitric oxide synthase
(S1177D) using ultrasound-enhanced destruction of plasmid-
loaded microbubbles improves vasoreactivity,” Circulation, vol.
105, no. 9, pp. 1104–1109, 2002.
[25] D. J. Rader, E. T. Alexander, G. L.Weibel, J. Billheimer, andG.H.
Rothblat, “The role of reverse cholesterol transport in animals
and humans and relationship to atherosclerosis,” Journal of
Lipid Research, vol. 50, pp. S189–S194, 2009.
[26] A. Rohatgi, A. Khera, J. D. Berry et al., “HDL cholesterol efflux
capacity and incident cardiovascular events,”The New England
Journal of Medicine, vol. 371, no. 25, pp. 2383–2393, 2014.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
